Healthcare Asia

06/01/2026

Radjak Hospital Group launched an Advanced Cardiac & Stroke Response Unit to accelerate treatment for Indonesia’s most time-critical cardiac and stroke emergencies. healthcareasiamagazine.com/healthcare/exclusive/radjak-launches-rapid-cardiac-stroke-unit-urban-emergencies?utm_source=Facebook&utm_campaign=organic_social&utm_medium=articles_2025

It may roll out the model across its urban hospitals as demand grows.

29/12/2025

The CGT landscape for respiratory diseases remains under pressure; however, ongoing R&D efforts hold promise for the treatment modality. healthcareasiamagazine.com/healthcare/in-focus/respiratory-cgt-development-remains-limited-funding-drops?utm_source=Facebook&utm_campaign=organic_social&utm_medium=articles_2025

The CGT landscape for respiratory diseases remains under pressure, with limited clinical progress and reduced funding.

26/12/2025

Mayapada Healthcare has started a group-wide effort to reduce errors that happen before lab samples are tested, an area where mistakes most often occur. healthcareasiamagazine.com/exclusive/mayapada-moves-cut-early-lab-mistakes?utm_source=Facebook&utm_campaign=organic_social&utm_medium=articles_2025

The aim is consistent test results across hospitals.

22/12/2025

The Healthcare Asia team is hitting the holiday pause button! We’ll be back on 5 January 2026. healthcareasiamagazine.com/in-focus/its-most-wonderful-time-year-7?utm_source=Facebook&utm_campaign=organic_social&utm_medium=articles_2025

The Healthcare Asia team is hitting the holiday pause button! We’ll be back on 5 January 2026.

22/12/2025

The global breast cancer drugs market is expected to reach $57.1b by 2031 at a 9.2% CAGR. healthcareasiamagazine.com/healthcare/in-focus/breast-cancer-drugs-market-be-valued-571b-2031?utm_source=Facebook&utm_campaign=organic_social&utm_medium=articles_2025

The global breast cancer drugs market, valued at $32.4b in 2024, is expected to reach $57.1b by 2031.

19/12/2025

Asia-Pacific healthcare accelerates AI adoption using hybrid infrastructure to scale care securely. https://bit.ly/3KZqeTK

17/12/2025

The cell and gene therapy market is expected to grow 34.2% annually through 2031 on the back of increased therapeutic approvals, a report said. healthcareasiamagazine.com/healthcare/in-focus/what-lies-ahead-cell-and-gene-therapy-market?utm_source=Facebook&utm_campaign=organic_social&utm_medium=articles_2025

The cell and gene therapy market is expected to grow 34.2% annually until 2031 on the back of increased therapeutic approvals.

17/12/2025

Asia-Pacific grows as global biotech hub through government support, research, and collaboration. https://bit.ly/3KT3hBN

17/12/2025

Indonesia.md secures exclusive rights to introduce advanced heart-assist device locally. https://bit.ly/4ad6OVQ

15/12/2025

Hong Kong will integrate private doctors, pharmacies, and allied health providers into district health centres to expand access and reduce pressure on public hospitals. healthcareasiamagazine.com/healthcare/exclusive/hong-kong-plans-wider-primary-care-network-in-reform-push?utm_source=Facebook&utm_campaign=organic_social&utm_medium=articles_2025

Hong Kong plans to bring private doctors, community pharmacies and allied health providers into district health centres.

12/12/2025

The Asia-Pacific is expected to be the fastest-growing medical device market in 2026, thanks to rising health expenditure and ongoing modernisation of health infrastructure.

The Asia-Pacific region is expected to be the fastest-growing medical device market in 2026, with an anticipated 9.3% expansion from 2025.

08/12/2025

Singapore’s pilot programme with Malaysia to fast-track medical device approvals could attract more medtech firms to the region, analysts said.

Singapore’s plan to speed up medical device approvals through a pilot programme with Malaysia could draw more medtech firms seeking a regional base.